vaccines

Leading health experts voice their support for the introduction of an EU priority review programme

(IN BRIEF) The global health NGO Deutsche Stiftung Weltbevölkerung (DSW) is calling on the European Union (EU) to establish a…

6 months ago

Kuehne+Nagel’s Rapid Response Delivers Flu Vaccines to 42 Veterans Affairs Hospitals Across the U.S.

(IN BRIEF) Kuehne+Nagel's North American Road Logistics team received an urgent request from a pharmaceutical customer to deliver 150 pallets…

6 months ago

AstraZeneca Highlights Long-Acting Antibodies and Vaccines for At-Risk Individuals at IDWeek Conference

(IN BRIEF) AstraZeneca is set to present new data at the 12th annual IDWeek conference, emphasizing the role of long-acting…

7 months ago

AstraZeneca to Present Data on Vaccines and Immune Therapies Portfolio at ECCMID 2023

(IN BRIEF) AstraZeneca is set to present data on its Vaccines and Immune Therapies portfolio at the European Congress of…

1 year ago

Smart exosomes from an Australian technology leader

(PRESS RELEASE) MELBOURNE, Australia, 3-Feb-2022 — /EuropaWire/ — Australian technologist Dr Ian Dixon founded Exopharm in 2013 with the vision…

2 years ago

SGS adds 550m2 and 16 BSL-2 laboratories to its Glasgow biosafety testing facility

(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion…

3 years ago

Kuehne+Nagel’s subsidiary QuickSTAT opens new control tower in Singapore for time-critical clinical trial logistics

(PRESS RELEASE) SINGAPORE, 22-Jul-2021 — /EuropaWire/ — Kuehne+Nagel, one of the world's leading logistics companies, has announced that its subsidiary…

3 years ago

Sanofi launches more impactful Corporate Social Responsibility (CSR) strategy

Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global…

3 years ago

Kuehne+Nagel takes responsibility of global distribution of Covid-19 Vaccine Moderna

New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 —…

3 years ago

Roche unveils new Anti-SARS-CoV-2 serology test to quantitatively measure antibodies in people exposed to SARS-CoV-2

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been…

4 years ago

Sanofi announces second collaboration as it strives to develop a novel COVID-19 vaccine candidate

(PRESS RELEASE) PARIS and LEXINGTON, MA, U.S.A, 27-Mar-2020 — /EuropaWire/ — Sanofi Pasteur collaborates with Translate Bio (NASDAQ: TBIO) to…

4 years ago

Wacker Chemie AG to acquire Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines from SynCo Bio Luxembourg S.à.r.l.

WACKER TAKES OVER SYNCO BIO PARTNERS OF AMSTERDAM CAPACITY OF ACQUIRED FERMENTATION PLANT FOR PHARMACEUTICAL ACTIVES TOTALS SOME 2,000 LITERS…

6 years ago

GSK further strengthens and expands its vaccines presence in US by establishing new global centre for vaccines R&D in Rockville, Maryland

New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint London and Philadelphia, 6-4-2015 — /EuropaWire/ — GSK…

9 years ago

International researchers discovery could lead to new means to combat malaria

14-6-2013 — /europawire.eu/ — Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford,…

11 years ago

EU-funded research project develops new diagnostic tool for malaria

Brussels, 29-4-2013 — /europawire.eu/ — An EU-funded research project aims to start testing a new diagnostic tool for malaria one year ahead…

11 years ago